Vortioxetine hydrobromid

 In recent years , there is a general tendency to take nootropic drugs to improve brain performance.For you,Vortioxetine hydrobromid may be a good choice.
Vortioxetine is an atypical antidepressant,it was discovered by scientists at Lundbeck who reported the rationale and synthesis for the drug (then called Lu AA21004) in a 2011 paper.In 2007, the compound was in Phase II clinical trials, and Lundbeck and Takeda entered into a partnership in which Takeda paid Lundbeck $40 million upfront, with promises of up to $345 million in milestone payments, and Takeda agreed to pay most of the remaining cost of developing the drug. The companies agreed to co-promote the drug in the US and Japan, and that Lundbeck would receive a royalty on all such sales. The deal included another drug candidate, tedatioxetine (Lu AA24530), and could be expanded to include two other Lundbeck compounds.
Vortioxetine was approved by the U.S. FDA for the treatment of major depressive disorder (MDD) in adults in September, 2013,and it was approved in Europe later that year.
Exactly how it works to treat depression is not known. It is thought to work by restoring the balance of serotonin, a natural substance in the brain, which helps to improve certain mood problems.
But,expert Kevin from Koffee Pharm Co.,Ltd told us Do NOT use vortioxetine if:you are allergic to any ingredient in vortioxetine,you have severe liver problems,you are taking or have taken a monoamine oxidase inhibitor (MAOI) (eg, phenelzine, selegiline) within the last 14 days,you are taking or have taken linezolid within the last 24 hours.